Sbir phase II: blood-plasma separation for point-of-care diagnostic testing
Ended Cooperative Agreement Awarded Last action
- Award ID
- 2111755
- Recipient
-
Lo Biosciences, Inc. UEI JPVWZEYKLXN3
- Awarding agency
-
National Science Foundation
- Obligated
- $1,126,590
Award facts
- Assistance listing
- 47.084 NSF Technology, Innovation, and Partnerships
- Completion date
- Originally
- Funding
-
- $1,118,590.00 Federal
- $8,000.00 Non-federal
- Place of performance
- Dorchester, MA 02125, USA
Award details come from USAspending.gov.
About this award
Hermes Life Sciences LTD received a $1,126,590 cooperative agreement award from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to support the SBIR PHASE II: BLOOD-PLASMA SEPARATION FOR POINT-OF-CARE DIAGNOSTIC TESTING project. The funding period is from August 1, 2021 through January 31, 2024. Under this cooperative agreement, Hermes Life Sciences LTD will develop technologies for blood-plasma separation to enable point-of-care diagnostic testing, in alignment with the NSF Technology, Innovation, and Partnerships program's goals of advancing science and engineering research leading to breakthrough technologies and solutions to national challenges.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $185,097 | $0 | |
| Amendment | $8,000 | $8,000 | |
| Original award | $925,493 | $0 |
Quick answers
Who received award 2111755?
2111755 was awarded to Lo Biosciences, Inc. by National Science Foundation on August 1, 2021.
How much is award 2111755 worth?
$1,126,590 has been obligated on 2111755: $1,118,590 in federal funding and $8,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award